Niko McCarty was Spectrum’s data reporter from 2021 to 2022. He has an M.A. from New York University’s Science, Health and Environmental Reporting Program. He also has an M.Res. in systems and synthetic biology from Imperial College London, where he was a Fulbright Scholar, and an M.Sc. in bioengineering from the California Institute of Technology. His prior research focused on engineered microbial communities and building CRISPR-Cas technologies.
Niko McCarty
Former data reporter
Spectrum
From this contributor
Neuroscience journal retracts 13 papers at once
The papers were flagged by a method that has now been called into question.
DNA unwinder tied to social behaviors in mice, zebrafish
Blocking the enzyme, called TOP2A, in embryos makes the animals less inclined to seek companionship later in life.
DNA unwinder tied to social behaviors in mice, zebrafish
Microscopy mash-up quantifies, maps neural circuits
A new method that merges tissue expansion, light-sheet microscopy and automated image segmentation can reconstruct neural circuits in about a week.
Microscopy mash-up quantifies, maps neural circuits
Autism brain signature most pronounced in sensory areas
An analysis of 11 cortical regions shows anterior-to-posterior shifts in gene expression linked to autism.
Autism brain signature most pronounced in sensory areas
New tool transforms, compares dissimilar brain maps
The open-source software makes it possible to overlay disparate datasets and potentially accelerate hypothesis generation.
New tool transforms, compares dissimilar brain maps
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.